Merck nears $6bn biotech deal to boost cancer drug pipeline
Home - Financial Times [Unofficial]
March 25, 2026
Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last year
Discussion in the ATmosphere